Title: Abstract: #88 Prevalence of Chronic Hepatitis C Virus Infection, US States and District of Columbia, 2013-2016 – Eli Rosenberg, et al. By Lucinda Porter, RN
The increase in injection drug use among younger people is driving an increase in the number of hepatitis C virus (HCV) infections. To prevent and treat hepatitis C, epidemiologists need to know where the highest prevalence exists in the United States. This study updated existing surveillance methods to obtain an accurate assessment.
These researchers estimated that during 2013-2016, nearly one percent of adults (2.5 million persons) in the United States had hepatitis C. Half of these infections were in nine states: Alaska, Arizona, Kentucky, Louisiana, New Mexico, Oklahoma, Oregon, Tennessee, West Virginia plus Washington, D.C.
Conclusion: These prevalence estimates support evidence-based evaluation and planning for HCV prevention, treatment, and ultimately elimination.
Editorial Comments: These high prevalence regions mirror many of the areas where there is a huge opioid problem. If effective measures are not put in place, hepatitis C transmission and reinfection rates will continue to climb. So will opioid-related injuries and deaths.Share This Page